Prøve GULL - Gratis
The monetary policy panel fired a bazooka in support of growth
Mint Hyderabad
|December 08, 2025
In its zeal to support growth, the committee may have overlooked the possible consequences for its mandate of price stability
“Baptism by fire,” is how D. Subbarao had described his initial months as the 22nd governor of the Reserve Bank of India (RBI).
Subbarao took charge in September 2008 in the shadow of the collapse of investment bank Lehman Brothers that led to the 2008-09 Global Financial Crisis and brought the world economy to its knees. In hindsight, his baptism was a relatively brief affair. Coordinated action by central banks saw the world economy recovering by mid-2009.
Contrast that with the trials of Sanjay Malhotra, appointed the 26th governor of RBI on 9 December 2024. Thanks to the shenanigans of the 47th President of the United States, Donald Trump, there seems to be no end to Governor Malhotra’s ‘baptism by fire’! Just days before his first Monetary Policy Committee (MPC) meeting in early February, President Trump fired his first salvo, signing three executive orders levying tariffs on Mexico, Canada and China.
By the next MPC meet in early April, Trump had fired his ‘Liberation Day’ bazooka, levying ‘reciprocal tariffs’ on most countries, including India. There’s been no let up since. Tariffs have been raised from 25% to 50%, exemptions have been granted selectively (arbitrarily?), our oil imports from Russia have come under fire, as also our exchange rate management. Meanwhile, US arm-twisting on an elusive US-India trade deal continues.
Denne historien er fra December 08, 2025-utgaven av Mint Hyderabad.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Hyderabad
Mint Hyderabad
Margin strain prompts wealth firms to expand
With a surge in affluent people, competition has intensified in the space
2 mins
December 10, 2025
Mint Hyderabad
Sam Altman's sprint to correct OpenAI's direction and fend off Google
The CEO is prioritizing achieving mass popularity through ChatGPT versus moonshot projects like artificial general intelligence
9 mins
December 10, 2025
Mint Hyderabad
Behind Paramount's relentless campaign to woo Warner Discovery, Donald Trump
Paramount Chief Executive David Ellison knew his latest bid for Warner Bros.
1 mins
December 10, 2025
Mint Hyderabad
Govt picks fund managers for ₹1 tn deep-tech boost
DST has appointed BIRAC and TDB, and is set to add Sidbi and SBI Funds Management soon
2 mins
December 10, 2025
Mint Hyderabad
Forgettable promos lead to ad fatigue for OTT viewers
Advertising on video-streaming services is increasingly resulting in viewer fatigue as platforms try to replace plateauing paid subscription revenue with ad money.
2 mins
December 10, 2025
Mint Hyderabad
Microsoft steps up India Al game with $17.5 billion
Data centre plan Microsoft's biggest Asia bet, total India commitment tops $20 bn
2 mins
December 10, 2025
Mint Hyderabad
WHY PORTFOLIO STRATEGY, NOT STOCK PICKING, DECIDES WHO WINS IN THE MARKET
When market context changes and focus shifts to new themes, equity investing must anticipate, prepare and respond.
3 mins
December 10, 2025
Mint Hyderabad
IndiGo courts rivals’ pilots as flight chaos sparks talent war
Under fire for mass cancellation of flights, India's largest air-carrier IndiGo has started calling up pilots at rival airlines who can fly Airbus planes, dangling hefty bonuses and asking them to join, as it struggles to stabilize operations.
2 mins
December 10, 2025
Mint Hyderabad
'Airlines' net profit likely $41 bn next yr'
Global airline trade body IATA said on Tuesday the airline sector would post record profits next year despite ongoing supply chain issues leading to slower aircraft deliveries and a delay in rolling out more fuel-efficient jets.
1 min
December 10, 2025
Mint Hyderabad
Novo moves HC to restrain Sun Pharma
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
1 mins
December 10, 2025
Listen
Translate
Change font size
